About Lanark Overseas Private Limited
Data last updated:
Lanark Overseas Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 July 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2002PTC116110. Its GSTIN is 06AAACL9314R1Z1 (Haryana).
The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹7.5 Lakh. It was formerly known as Lanark Overseas Limited. It is led by directors Verinder Chhabra and Dinesh Kakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 913 D Mall Netaji Subhash Place, Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.01 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹48,852 (net margin 48.6%) and EBITDA of ₹68,376 (EBITDA margin 68%).
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lanarklab.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address913 D Mall Netaji Subhash Place, Pitampura, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Lanark Overseas Private Limited FY 2025 filings available
Lanark Overseas Private Limited reported revenue of ₹1.01 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Lanark Overseas Private Limited
Revenue rose 1% in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lanark Overseas Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹68,376 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹48,852 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lanark Overseas Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 68% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 48.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lanark Overseas are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lanark Overseas Private Limited
Lanark Overseas Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Keeminds Formulation Private Limited | ₹1.02 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Wincy Crome Pharma Private Limited | ₹1.01 Lakh (FY 2025) | •••• | •••• | •••• | Hubli, Karnataka, India | |
| Aral Pharma Private Limited | ₹1.01 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Indore, Madhya Pradesh, India |
| Pole-Star Ventures Private Limited | ₹1.01 Lakh (FY 2024) | •••• | •••• | 15538400.0% | •••• | Chennai, Tamil Nadu, India |
| Prime RMC Private Limited | ₹1.01 Lakh (FY 2024) | •••• | •••• | •••• | Jammu, Jammu and Kashmir, India | |
| Lanark Overseas Private Limited this company | ₹1.01 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Delhi, India |
| Sandiaz Lab Private Limited | ₹1 Lakh (FY 2025) | •••• | •••• | -93.0% | •••• | Pune, Maharashtra, India |
| Adlife Healthcare Private Limited | ₹1 Lakh (FY 2022) | •••• | •••• | 659.0% | •••• | Mumbai, Maharashtra, India |
| Blockceuticals Private Limited | ₹1 Lakh (FY 2025) | •••• | •••• | •••• | Nagaur, Rajasthan, India | |
| Debakey Life Sciences Private Limited | ₹99,187 (FY 2019) | •••• | •••• | 183.0% | •••• | Ongole, Andhra Pradesh, India |
| BLG Pharma Private Limited | ₹98,518 (FY 2025) | •••• | •••• | -9.0% | •••• | Gorakhpur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Lanark Overseas by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Lanark Overseas Private Limited
Lanark Overseas Private Limited is audited by TAGEJA R & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TAGEJA R & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Lanark Overseas Private Limited
Lanark Overseas has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Verinder Chhabra Also directs: Klokter Life Sciences Private Limited, Zee Biosciences Private Limited, Zee Parenteral Private Limited and 5 more | Director | 18 Mar 2022 | 4 Years 6 Months | Current |
| Dinesh Kakar Also directs: Klokter Life Sciences Private Limited, Lanark Laboratories Pvt Ltd, Antek Drugs Private Limited and 5 more | Director | 21 Nov 2003 | 22 Years 10 Months | Current |
Ownership and Shareholding of Lanark Overseas Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lanark Overseas Private Limited
Lanark Overseas Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Lanark Overseas Private Limited
Lanark Overseas Private Limited has 1 court case on record: 1 filed by Lanark Overseas. All case is disposed. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Civil suit | Filed by the company against Acemicromatic Manufacturing Intelligence Technologies Private Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Lanark Overseas Private Limited
Employment history and EPFO contributions of people linked to Lanark Overseas.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Lanark Overseas Private Limited
Lanark Overseas has one previous CIN (Corporate Identification Number): U51909DL2002PLC116110. The current CIN is U51909DL2002PTC116110, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909DL2002PTC116110 | Current |
| U51909DL2002PLC116110 | Previous |
Recent Activity on Lanark Overseas Private Limited
Lanark Overseas Private Limited has 6 board changes on record since 2003: 2 appointments and 4 cessations. The latest: Verinder Chhabra ceased to be Additional Director on 27 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Lanark Overseas Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lanark Overseas Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lanark Overseas Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lanark Overseas Private Limited
Lanark Overseas has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACL9314R1Z1 | Haryana | Active | 25 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lanark Overseas Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lanark Overseas Private Limited
Lanark Overseas is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 July 2002 (24+ years old) and is registered under CIN U51909DL2002PTC116110.
Lanark Overseas reported revenue of ₹1.01 Lakh for FY 2024 (up 1% YoY).
Lanark Overseas has 2 current directors:
- Verinder Chhabra - Director
- Dinesh Kakar - Director
Lanark Overseas reported a net profit of ₹48,852 (net margin 48.6%) and EBITDA of ₹68,376 (EBITDA margin 68%) for FY 2024, as per its filed financial statements.
The GSTIN of Lanark Overseas is 06AAACL9314R1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Lanark Overseas is U51909DL2002PTC116110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lanark Overseas has 1 court case on record: 1 filed by the company.
Lanark Overseas was incorporated on 05 July 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lanark Overseas by revenue are Keeminds Formulation Private Limited, Wincy Crome Pharma Private Limited, Aral Pharma Private Limited, Pole-Star Ventures Private Limited, Prime RMC Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Verinder Chhabra ceased to be Additional Director on 27 Sep 2022. Rajeev Mukul ceased to be Director on 24 Mar 2022. Rohan Mukul ceased to be Director on 24 Mar 2022. Lanark Overseas has 6 board changes on record in total.
Lanark Overseas can be reached through the website lanarklab.com. Its registered office is in Delhi, India.